Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Commentary
  • Published:

Hematopoietic growth factors in acute leukemia

Abstract

The hematopoietic growth factors are glycoproteins that can be produced by recombinant DNA technology. They have many potential clinical uses in acute leukemia; several areas have been explored extensively and much data are available from clinical trials. Other areas are of potential interest, but have a paucity of clinical information. The past decade has seen major strides in the development and clinical application of cytokines in acute leukemia and it is expected that this trend will continue over the next decade as further areas are explored and results of clinical trials mature to enable us to determine the precise role of cytokines in the clinical setting.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rowe, J., Liesveld, J. Hematopoietic growth factors in acute leukemia. Leukemia 11, 328–341 (1997). https://doi.org/10.1038/sj.leu.2400592

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2400592

Keywords

This article is cited by

Search

Quick links